Mural Oncology Ownership | Who Owns Mural Oncology?
Mural Oncology Ownership Summary
Mural Oncology is owned by 54.96% institutional investors, 1.62% insiders, and 43.42% retail investors. Cranbrook wealth management is the largest institutional shareholder, holding 0% of MURA shares.
MURA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mural Oncology | 54.96% | 1.62% | 43.42% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Cranbrook wealth management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Cranbrook wealth management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cranbrook wealth management | - | - | -4.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cranbrook wealth management | - | - | -4.00 |
Sold Out
Holder | Change |
---|---|
Cranbrook wealth management | -4.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 74 | 5.71% | 9,381,197 | -1.48% | 54 | 1.76% | 26 | 18.18% | 23 | -11.54% |
Sep 30, 2024 | 70 | -14.63% | 9,521,654 | -12.63% | 55 | 1.35% | 22 | -31.25% | 26 | -16.13% |
Jun 30, 2024 | 82 | -14.58% | 10,897,815 | -9.88% | 64 | 1.24% | 32 | 6.67% | 31 | -34.04% |
Mar 31, 2024 | 96 | -20.66% | 12,092,738 | -9.53% | 72 | 1.12% | 30 | -75.00% | 47 | - |
Dec 31, 2023 | 121 | - | 13,366,680 | - | 80 | - | 120 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 04, 2025 | Keson-Brookes Maiken | See Remarks | Sell | $4.24K |
Mar 05, 2025 | Keson-Brookes Maiken | See Remarks | Sell | $5.07K |
Mar 04, 2025 | Loew Caroline | Chief Executive Officer | Sell | $14.49K |
Feb 24, 2025 | Goodman Vicki L | Chief Medical Officer | Sell | $51.29K |
Dec 23, 2024 | Keson-Brookes Maiken | See Remarks | Sell | $8.35K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 4 |
2024 Q4 | - | 4 |
2024 Q3 | 1 | 2 |
2023 Q4 | - | - |
MURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools